Stephane Bancel is Chief Executive Officer of Moderna, Inc.. Currently has a direct ownership of 5.49 Million shares of MRNA, which is worth approximately $436 Million. The most recent transaction as insider was on Oct 13, 2022, when has been sold 40,000 shares (Common Stock) at a price of $131.93 per share, resulting in proceeds of $5,277,200. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.49M
0.49% 3M change
1.39% 12M change
Total Value Held $436 Million

Stephane Bancel Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 13 2022
SELL
Open market or private sale
$5,277,200 $131.93 p/Share
40,000 Reduced 0.73%
5,411,946 Common Stock
Oct 13 2022
BUY
Exercise of conversion of derivative security
$39,600 $0.99 p/Share
40,000 Added 0.73%
5,451,946 Common Stock
Oct 12 2022
SELL
Open market or private sale
$5,314,000 $132.85 p/Share
40,000 Reduced 0.73%
5,411,946 Common Stock
Oct 12 2022
BUY
Exercise of conversion of derivative security
$39,600 $0.99 p/Share
40,000 Added 0.73%
5,451,946 Common Stock
Oct 06 2022
SELL
Open market or private sale
$4,989,200 $124.73 p/Share
40,000 Reduced 0.73%
5,411,946 Common Stock
Oct 06 2022
BUY
Exercise of conversion of derivative security
$39,600 $0.99 p/Share
40,000 Added 0.73%
5,451,946 Common Stock
Oct 05 2022
SELL
Open market or private sale
$4,974,400 $124.36 p/Share
40,000 Reduced 0.73%
5,411,946 Common Stock
Oct 05 2022
BUY
Exercise of conversion of derivative security
$39,600 $0.99 p/Share
40,000 Added 0.73%
5,451,946 Common Stock
Sep 29 2022
SELL
Open market or private sale
$4,683,200 $117.08 p/Share
40,000 Reduced 0.73%
5,411,946 Common Stock
Sep 29 2022
BUY
Exercise of conversion of derivative security
$39,600 $0.99 p/Share
40,000 Added 0.73%
5,451,946 Common Stock
Sep 28 2022
SELL
Open market or private sale
$4,934,400 $123.36 p/Share
40,000 Reduced 0.73%
5,411,946 Common Stock
Sep 28 2022
BUY
Exercise of conversion of derivative security
$39,600 $0.99 p/Share
40,000 Added 0.73%
5,451,946 Common Stock
Sep 22 2022
SELL
Open market or private sale
$5,002,400 $125.06 p/Share
40,000 Reduced 0.73%
5,411,946 Common Stock
Sep 22 2022
BUY
Exercise of conversion of derivative security
$39,600 $0.99 p/Share
40,000 Added 0.73%
5,451,946 Common Stock
Sep 21 2022
SELL
Open market or private sale
$5,159,600 $128.99 p/Share
40,000 Reduced 0.73%
5,411,946 Common Stock
Sep 21 2022
BUY
Exercise of conversion of derivative security
$39,600 $0.99 p/Share
40,000 Added 0.73%
5,451,946 Common Stock
Sep 15 2022
SELL
Open market or private sale
$5,484,000 $137.1 p/Share
40,000 Reduced 0.73%
5,411,946 Common Stock
Sep 15 2022
BUY
Exercise of conversion of derivative security
$39,600 $0.99 p/Share
40,000 Added 0.73%
5,451,946 Common Stock
Sep 14 2022
SELL
Open market or private sale
$5,574,400 $139.36 p/Share
40,000 Reduced 0.73%
5,411,946 Common Stock
Sep 14 2022
BUY
Exercise of conversion of derivative security
$39,600 $0.99 p/Share
40,000 Added 0.73%
5,451,946 Common Stock
Sep 08 2022
SELL
Open market or private sale
$5,616,400 $140.41 p/Share
40,000 Reduced 0.73%
5,411,946 Common Stock
Sep 08 2022
BUY
Exercise of conversion of derivative security
$39,600 $0.99 p/Share
40,000 Added 0.73%
5,451,946 Common Stock
Sep 07 2022
SELL
Open market or private sale
$5,354,400 $133.86 p/Share
40,000 Reduced 0.73%
5,411,946 Common Stock
Sep 07 2022
BUY
Exercise of conversion of derivative security
$39,600 $0.99 p/Share
40,000 Added 0.73%
5,451,946 Common Stock
Sep 01 2022
SELL
Open market or private sale
$5,356,400 $133.91 p/Share
40,000 Reduced 0.73%
5,411,946 Common Stock
Stephane Bancel

Stephane Bancel

Chief Executive Officer
Cambridge, MA

Track Institutional and Insider Activities on MRNA

Follow Moderna, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

News

Receive news related to Moderna, Inc.

Track Activities on MRNA